Expand Your Capabilities and Speed Time-to-Clinic With the Perfect Combination of Technology and Expertise
Get Insight Into the Facility of Our Trusted Cell Line Development Services
When it comes to the commercialization of biologics, effective, high-quality cell line development (CLD) is essential for success. The key to minimizing risk and optimizing outcomes is having a reliable partner that offers both cell line development experience and expertise and a comprehensive portfolio of innovative products and services that help take your molecule from DNA to GMP Master Cell Bank.
This webinar will highlight the cell line development workflow required to produce stable and scalable clones that are ready to be used in a clinical or commercial setting. It will review the full suite of Sartorius’ CLD services, including bioanalytical testing, master cell banking and biosafety testing, as well as the extensive cell line development experience we bring to every project.
You will be introduced to Sartorius experts who can answer your questions, and you will learn about our state-of-the-art Cell Culture Technology Center in Ulm, Germany, which features special laboratories designed to develop cell lines and optimize cell culture media.
What Will You Learn:
- Understand the drug development process, from cell line development (CLD) to Master Cell Bank
- Explore the benefits of outsourcing cell line development to an external partner such as Sartorius
- Identify what to consider when evaluating external providers of CLD products and services
- Learn about Sartorius’ CLD Protein Expression technology and capabilities
Meet Our Expert:
アデモラ・カシム、MBA
ザルトリウス、細胞株開発担当製品スペシャリスト
アデモラ・カシムは、ザルトリウスの細胞株・培地・試験ソリューション(CMTS)部門の細胞株開発担当製品スペシャリストです。アデモラは、ミズーリ大学で生物学の学士号、イリノイ大学で医療バイオテクノロジーの修士号、ウェブスター大学でMBAを取得しています。
バイオプロセス業界で10年以上の経験があります。ザルトリウスに入社する前は、MilliporeSigmaのプロダクトマネージャーとして、バイオ医薬品業界で一般的に使用されている細胞株、細胞培養培地、バイオプロセスサービスのポートフォリオの開発と管理を支援しました。この役職に就く前は、R&Dサイエンティストとして細胞株開発およびエンジニアリング部門で、組換えタンパク質の効率的な製造のためのさまざまなCHO細胞株の開発に携わっていました。
